{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:09:13Z","timestamp":1785805753789,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.brainres.2024.148881","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T02:13:36Z","timestamp":1710987216000},"page":"148881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Neuropsychiatric symptoms profile and markers of Alzheimer disease\u2013type pathology in patients with Lewy body dementias"],"prefix":"10.1016","volume":"1833","author":[{"given":"Chaofan","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.brainres.2024.148881_b0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jagp.2020.01.012","article-title":"The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum","volume":"28","author":"Banning","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-021-00456-1","article-title":"Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns","volume":"16","author":"Chen","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.brainres.2024.148881_b0015","doi-asserted-by":"crossref","first-page":"e0179399","DOI":"10.1371\/journal.pone.0179399","article-title":"Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease","volume":"12","author":"Chiu","year":"2017","journal-title":"PLoS One."},{"issue":"10","key":"10.1016\/j.brainres.2024.148881_b0020","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1002\/alz.13357","article-title":"Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort","volume":"19","author":"Choudhury","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"Pt 5","key":"10.1016\/j.brainres.2024.148881_b0025","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain."},{"issue":"7","key":"10.1016\/j.brainres.2024.148881_b0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jalz.2018.02.006","article-title":"The stability of neuropsychiatric subsyndromes in Alzheimer's disease","volume":"14","author":"Connors","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.27867","article-title":"Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases","volume":"35","author":"Coughlin","year":"2020","journal-title":"Mov Disord."},{"issue":"2","key":"10.1016\/j.brainres.2024.148881_b0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders","volume":"85","author":"Coughlin","year":"2019","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.brainres.2024.148881_b0045","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamaneurol.2023.1835","article-title":"Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis","volume":"80","author":"d'Angremont","year":"2023","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.brainres.2024.148881_b0050","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/alz.12335","article-title":"Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria","volume":"17","author":"De Mauleon","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.brainres.2024.148881_b0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2021.4363","article-title":"Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias","volume":"79","author":"Devanand","year":"2022","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp-2019-320980","article-title":"CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies","volume":"91","author":"Di Censo","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"issue":"4","key":"10.1016\/j.brainres.2024.148881_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad207","article-title":"Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias","volume":"5","author":"Fallon","year":"2023","journal-title":"Brain Commun."},{"issue":"3","key":"10.1016\/j.brainres.2024.148881_b0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","article-title":"The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to disease duration in dementia with Lewy bodies","volume":"14","author":"Ferman","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.brainres.2024.148881_b0075","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-170001","article-title":"Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study","volume":"59","author":"Gatchel","year":"2017","journal-title":"J Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.brainres.2024.148881_b0080","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2012.12.001","article-title":"Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future","volume":"9","author":"Geda","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaneurol.2021.4222","article-title":"Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies","volume":"79","author":"Gonzalez","year":"2022","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2024.148881_b0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bpa.12182","article-title":"Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias","volume":"25","author":"Howlett","year":"2015","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.brainres.2024.148881_b0100","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000444","article-title":"The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders","volume":"8","author":"Irwin","year":"2018","journal-title":"J. Alzheimers Dis. Parkinsonism."},{"issue":"12","key":"10.1016\/j.brainres.2024.148881_b0105","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","article-title":"CSF tau and beta-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders","volume":"90","author":"Irwin","year":"2018","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/alz.13398","article-title":"ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium","volume":"20","author":"Jain","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.brainres.2024.148881_b0115","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00702-023-02669-8","article-title":"Depression in dementia with Lewy bodies: a critical update","volume":"130","author":"Jellinger","year":"2023","journal-title":"J Neural Transm (vienna)."},{"issue":"4","key":"10.1016\/j.brainres.2024.148881_b0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1474-4422(19)30290-X","article-title":"Dementia in China: epidemiology, clinical management, and research advances","volume":"19","author":"Jia","year":"2020","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.brainres.2024.148881_b0130","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.brainres.2024.148881_b0135","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1002\/alz.12557","article-title":"Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging","volume":"19","author":"Krell-Roesch","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.brainres.2024.148881_b0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","article-title":"Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies","volume":"88","author":"Lemstra","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"issue":"5","key":"10.1016\/j.brainres.2024.148881_b0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.2016.15020248","article-title":"Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study","volume":"173","author":"Leonpacher","year":"2016","journal-title":"Am J Psychiatry."},{"issue":"8","key":"10.1016\/j.brainres.2024.148881_b0150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1017\/S1041610217002630","article-title":"Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease","volume":"30","author":"Liu","year":"2018","journal-title":"Int Psychogeriatr."},{"issue":"10113","key":"10.1016\/j.brainres.2024.148881_b0155","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.brainres.2024.148881_b0160","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jalz.2019.02.002","article-title":"Effects of single and combined immunotherapy approach targeting amyloid beta protein and alpha-synuclein in a dementia with Lewy bodies-like model","volume":"15","author":"Mandler","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.brainres.2024.148881_b0165","doi-asserted-by":"crossref","first-page":"e5993","DOI":"10.1002\/gps.5993","article-title":"Contribution of amyloid and putative Lewy body pathologies in neuropsychiatric symptoms","volume":"38","author":"Matsuoka","year":"2023","journal-title":"Int. J. Geriatr. Psychiatry."},{"issue":"3 Suppl","key":"10.1016\/j.brainres.2024.148881_b0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.brainres.2024.148881_b0180","article-title":"Sex differences in brain atrophy in dementia with Lewy bodies","author":"Oltra","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.brainres.2024.148881_b0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.07.008","article-title":"Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies","volume":"31","author":"Peavy","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl 9","key":"10.1016\/j.brainres.2024.148881_b0190","first-page":"S42","article-title":"Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort","volume":"19","author":"Polsinelli","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.brainres.2024.148881_b0195","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1474-4422(16)00116-2","article-title":"The new definition and diagnostic criteria of Parkinson's disease","volume":"15","author":"Postuma","year":"2016","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2024.148881_b0200","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1176\/appi.ajp.2011.11010009","article-title":"Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia","volume":"169","author":"Purandare","year":"2012","journal-title":"Am. J. Psychiatry."},{"issue":"7","key":"10.1016\/j.brainres.2024.148881_b0205","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain."},{"issue":"12","key":"10.1016\/j.brainres.2024.148881_b0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid beta 1\u201342 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.brainres.2024.148881_b0215","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/jamaneurol.2022.1133","article-title":"Clinical Manifestations of early-onset dementia with Lewy bodies compared with late-onset dementia with lewy bodies and early-onset Alzheimer disease","volume":"79","author":"Sim","year":"2022","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2024.148881_b0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.brainres.2024.148881_b0225","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1055\/s-0043-1777774","article-title":"Behavioral or neuropsychiatric symptoms of Alzheimer's disease: from psychopathology to pharmacological management","volume":"81","author":"Teixeira","year":"2023","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.brainres.2024.148881_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120815","article-title":"Clinical characteristics of pathological confirmed prodromal dementia with Lewy bodies","volume":"453","author":"Ting","year":"2023","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/alz.12814","article-title":"Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design","volume":"19","author":"Toledo","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.brainres.2024.148881_b0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.289.2.210","article-title":"Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis","volume":"289","author":"Trinh","year":"2003","journal-title":"JAMA."},{"issue":"5","key":"10.1016\/j.brainres.2024.148881_b0245","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/ana.26635","article-title":"Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia","volume":"93","author":"Tropea","year":"2023","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-014-0090-1","article-title":"The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease","volume":"7","author":"Vermeiren","year":"2015","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.brainres.2024.148881_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2020.104268","article-title":"Sarcopenia and frailty in individuals with dementia: A systematic review","volume":"92","author":"Waite","year":"2021","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.brainres.2024.148881_b0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2022.05.022","article-title":"Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers","volume":"100","author":"Walker","year":"2022","journal-title":"Parkinsonism Relat Disord."},{"issue":"5","key":"10.1016\/j.brainres.2024.148881_b0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jnc.14698","article-title":"Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions","volume":"150","author":"Walker","year":"2019","journal-title":"J Neurochem."},{"issue":"1","key":"10.1016\/j.brainres.2024.148881_b0270","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41398-022-02269-2","article-title":"Modified dementia risk score as a tool for the prediction of dementia: a prospective cohort study of 239745 participants","volume":"12","author":"Wang","year":"2022","journal-title":"Transl Psychiatry."},{"key":"10.1016\/j.brainres.2024.148881_b0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbi.2021.03.019","article-title":"Inflammation, negative affect, and amyloid burden in Alzheimer's disease: Insights from the kynurenine pathway","volume":"95","author":"Willette","year":"2021","journal-title":"Brain Behav. Immun."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T12:10:10Z","timestamp":1714651810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899324001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":55,"alternative-id":["S0006899324001355"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2024.148881","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric symptoms profile and markers of Alzheimer disease\u2013type pathology in patients with Lewy body dementias","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2024.148881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148881"}}